Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
Sarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
Sarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
Submitted by
admin
on September 20, 2016 - 9:49am
Source:
Stat/Pharmalot
News Tags:
Sarepta Therapeutics
Duchenne Muscular Dystrophy
drug pricing
eteplirsen
Headline:
Sarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
Do Not Allow Advertisers to Use My Personal information
